Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,724,337
  • Shares Outstanding, K 93,455
  • Annual Sales, $ 258,610 K
  • Annual Income, $ -850 K
  • 36-Month Beta 0.79
  • Price/Sales 6.13
  • Price/Cash Flow 56.12
  • Price/Book 5.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.04
  • Number of Estimates 2
  • High Estimate 0.04
  • Low Estimate 0.03
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.56 +18.89%
on 01/22/19
18.71 -1.12%
on 02/20/19
+2.68 (+16.94%)
since 01/18/19
3-Month
11.05 +67.42%
on 12/24/18
18.71 -1.12%
on 02/20/19
+2.84 (+18.14%)
since 11/21/18
52-Week
7.71 +139.95%
on 04/02/18
19.04 -2.84%
on 11/01/18
+10.42 (+128.96%)
since 02/21/18

Most Recent Stories

More News
Neogenomics Inc Shares Up 42.2% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 1 month, Neogenomics Inc has returned 42.19% as of today's recent price of $18.52.

NEO : 18.50 (+0.27%)
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter and full year 2018.

NEO : 18.50 (+0.27%)
NeoGenomics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 19, 2019 / NeoGenomics, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 19, 2019 at 8:30 AM Eastern...

NEO : 18.50 (+0.27%)
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount

Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount

RC : 16.04 (+1.65%)
NEO : 18.50 (+0.27%)
DGII : 13.56 (+0.30%)
GAIN : 11.98 (+1.61%)
PGRE : 14.61 (+0.14%)
NeoGenomics (NEO) Reports Next Week: What to Know Ahead of the Release

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEO : 18.50 (+0.27%)
5 Breakout Stocks for Stellar Returns

This method involves zeroing in on stocks whose prices vary within a narrow band.

RC : 16.04 (+1.65%)
NEO : 18.50 (+0.27%)
DGII : 13.56 (+0.30%)
GAIN : 11.98 (+1.61%)
PGRE : 14.61 (+0.14%)
Neogenomics Inc Shares Up 29.8% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 4 weeks, Neogenomics Inc has returned 29.83% as of today's recent price of $16.91.

NEO : 18.50 (+0.27%)
Neogenomics Inc Has Returned 28.0% Since SmarTrend Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 3 weeks, Neogenomics Inc has returned 27.98% as of today's recent price of $16.67.

NEO : 18.50 (+0.27%)
Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year?

Is (NEO) Outperforming Other Medical Stocks This Year?

NEO : 18.50 (+0.27%)
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth quarter and fiscal year 2018 financial results on Tuesday,...

NEO : 18.50 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 19.01
1st Resistance Point 18.76
Last Price 18.50
1st Support Level 18.17
2nd Support Level 17.83

See More

52-Week High 19.04
Last Price 18.50
Fibonacci 61.8% 14.71
Fibonacci 50% 13.38
Fibonacci 38.2% 12.04
52-Week Low 7.71

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar